United Kingdom Diabetes Care Devices Market Outlook to 2022 - Glucose Monitoring and Insulin Delivery - Product Image

United Kingdom Diabetes Care Devices Market Outlook to 2022 - Glucose Monitoring and Insulin Delivery

  • ID: 4031187
  • Report
  • Region: United Kingdom, Great Britain
  • 149 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • B. Braun Melsunge
  • Bayer HealthCare AG
  • Becton Dickinson and Co
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • MORE
United Kingdom Diabetes Care Devices Market Outlook to 2022 - Glucose Monitoring and Insulin Delivery

Summary

The author's new report, "United Kingdom Diabetes Care Devices Market Outlook to 2022", provides key market data on the United Kingdom Diabetes Care Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories - Glucose Monitoring and Insulin Delivery.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size for Diabetes Care Devices market categories - Glucose Monitoring and Insulin Delivery.
- Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2008 to 2015 and forecast to 2022.
- 2015 company shares and distribution shares data for Diabetes Care Devices market.
- Global corporate-level profiles of key companies operating within the United Kingdom Diabetes Care Devices market.
- Key players covered include LifeScan Inc, Bayer HealthCare AG, F. Hoffmann-La Roche Ltd and others.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • B. Braun Melsunge
  • Bayer HealthCare AG
  • Becton Dickinson and Co
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • MORE
1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 What Is This Report About?

2.2 Diabetes Care Devices Market Segmentation

2.3 Definitions of Markets Covered in the Report

3 Diabetes Care Devices Market, United Kingdom

3.1 Diabetes Care Devices Market, United Kingdom, Revenue ($m), 2008-2022

3.2 Diabetes Care Devices Market, United Kingdom, Revenue Mix ($m), 2015

3.3 Diabetes Care Devices Market, United Kingdom, Category Contribution by Revenue ($m), 2015

3.4 Diabetes Care Devices Market, United Kingdom, Revenue ($m), 2008-2015

3.5 Diabetes Care Devices Market, United Kingdom, Revenue ($m), 2015-2022

3.6 Diabetes Care Devices Market, United Kingdom, Volume (Units), 2008-2022

3.7 Diabetes Care Devices Market, United Kingdom, Volume (Units), 2008-2015

3.8 Diabetes Care Devices Market, United Kingdom, Volume (Units), 2015-2022

3.9 Diabetes Care Devices Market, United Kingdom, Company Share by Revenue ($m), 2015

4 Glucose Monitoring Market, United Kingdom

4.1 Glucose Monitoring Market, United Kingdom, Revenue Mix ($m), 2015

4.2 Glucose Monitoring Market, United Kingdom, Segment Contribution (%), 2015

4.3 Glucose Monitoring Market, United Kingdom, Revenue ($m), 2008-2015

4.4 Glucose Monitoring Market, United Kingdom, Revenue ($m), 2015-2022

4.4.1 Blood Glucose Meters Market, United Kingdom, Revenue ($m), by Segment, 2008-2015

4.4.2 Blood Glucose Meters Market, United Kingdom, Revenue ($m), by Segment, 2015-2022

4.5 Glucose Monitoring Market, United Kingdom, Volume (Units), 2008-2015

4.6 Glucose Monitoring Market, United Kingdom, Volume (Units), 2015-2022

4.6.1 Blood Glucose Meters Market, United Kingdom, Volume (Units), by Segment, 2008-2015

4.6.2 Blood Glucose Meters Market, United Kingdom, Volume (Units), by Segment, 2015-2022

4.7 Glucose Monitoring Market, United Kingdom, Distribution Share by Revenue ($m), 2014-2015

4.8 Glucose Monitoring Market, United Kingdom, Company Share by Revenue ($m), 2015

5 Insulin Delivery Market, United Kingdom

5.1 Insulin Delivery Market, United Kingdom, Revenue Mix ($m), 2015

5.2 Insulin Delivery Market, United Kingdom, Segment Contribution (%), 2015

5.3 Insulin Delivery Market, United Kingdom, Revenue ($m), 2008-2015

5.4 Insulin Delivery Market, United Kingdom, Revenue ($m), 2015-2022

5.4.1 Insulin Pens Market, United Kingdom, Revenue ($m), by Segment, 2008-2015

5.4.2 Insulin Pumps Market, United Kingdom, Revenue ($m), by Segment, 2008-2015

5.4.3 Insulin Pens Market, United Kingdom, Revenue ($m), by Segment, 2015-2022

5.4.4 Insulin Pumps Market, United Kingdom, Revenue ($m), by Segment, 2015-2022

5.5 Insulin Delivery Market, United Kingdom, Volume (Units), 2008-2015

5.6 Insulin Delivery Market, United Kingdom, Volume (Units), 2015-2022

5.6.1 Insulin Pens Market, United Kingdom, Volume (Units), by Segment, 2008-2015

5.6.2 Insulin Pumps Market, United Kingdom, Volume (Units), by Segment, 2008-2015

5.6.3 Insulin Pens Market, United Kingdom, Volume (Units), by Segment, 2015-2022

5.6.4 Insulin Pumps Market, United Kingdom, Volume (Units), by Segment, 2015-2022

5.7 Insulin Delivery Market, United Kingdom, Distribution Share by Revenue ($m), 2014-2015

5.8 Insulin Delivery Market, United Kingdom, Company Share by Revenue ($m), 2015

6 Overview of Key Companies in United Kingdom, Diabetes Care Devices Market

6.1 F. Hoffmann-La Roche Ltd

6.1.1 Company Overview

6.2 Sanofi

6.2.1 Company Overview

6.3 LifeScan Inc

6.3.1 Company Overview

6.4 Bayer HealthCare AG

6.4.1 Company Overview

6.5 Becton Dickinson and Co

6.5.1 Company Overview

6.6 Abbott Laboratories

6.6.1 Company Overview

6.7 Eli Lilly and Company

6.7.1 Company Overview

6.8 Novo Nordisk A/S

6.8.1 Company Overview

6.9 B. Braun Melsungen AG

6.9.1 Company Overview

6.10 Medtronic plc

6.10.1 Company Overview

6.11 Ypsomed Holding AG

6.11.1 Company Overview

6.12 A. Menarini Diagnostics S.r.l.

6.12.1 Company Overview

7 Diabetes Care Devices Market Pipeline Products

8 Financial Deals Landscape

8.1 Equity Offerings

8.1.1 Midatech Pharma Raises USD14.9 Million in Private Placement of Shares

8.1.2 EKF Diagnostics Raises USD7 Million in Private Placement of Shares

8.1.3 HCi Viocare to Raise up to USD34 Million in Public Offering of Shares

8.2 Partnerships

8.2.1 JDRF Enters into Co-Development Agreement with Arecor

8.2.2 Tandem Diabetes Care Enters into Licensing Agreement with TypeZero Technologies

8.2.3 Senseonics Amends its Distribution Agreement with F. Hoffmann-La Roche

8.2.4 Medtronic and Qualcomm Life Enter into Co-Development Agreement

8.2.5 Metabolon Enters into Licensing Agreement with Synlab

8.2.6 Cellnovo Enters into Agreement with Roche Diagnostics

9 Recent Developments

9.1 Corporate Communications

9.1.1 Dec 02, 2016: Cambridge University Hospitals appoints new COO

9.1.2 Nov 24, 2016: Smiths announces new Non-executive Director

9.1.3 Nov 09, 2016: Change To Astrazeneca Board Of Directors

9.1.4 Sep 28, 2016: Change To Astrazeneca Board Of Directors

9.1.5 Sep 09, 2016: Tunstall Announces New Chief Executive Officer

9.1.6 Jul 11, 2016: EKF Diagnostics Holdings Appoints Carl Dominic Contadini As Non-Executive Director

9.1.7 Jun 09, 2016: Cellnovo appoints John Brooks as Chairman of the Board of Directors

9.1.8 May 09, 2016: EKF Diagnostics Announces Directorate Change

9.1.9 Apr 27, 2016: Smiths announces new Non-executive Director

9.1.10 Apr 20, 2016: EKF Diagnostics Holdings Announces Directorate Change

9.1.11 Apr 08, 2016: EKF Diagnostics Holdings Announces Directorate Change

9.1.12 Jan 28, 2016: LivaNova Receives Regulatory Approval in Japan for KORA 250

9.1.13 Jan 14, 2016: John Crane management change

9.2 Financial Announcements

9.2.1 Nov 10, 2016: AstraZeneca: Year-To-Date and Q3 2016 Results

9.2.2 Sep 28, 2016: Smiths Group: Annual results for the year ended 31 July 2016

9.2.3 Sep 12, 2016: EKF Diagnostics Holdings: Half-year Report

9.2.4 Sep 02, 2016: Midatech Pharma: Interim results for the six months ended 30 June 2016

9.2.5 Jul 28, 2016: AstraZeneca: H1 2016 Results

9.2.6 Apr 13, 2016: Midatech Pharma Announces Audited financial results for the year ended 31 December 2015

9.2.7 Apr 13, 2016: Midatech Pharma Audited financial results for the year ended 31 December 2015

9.2.8 Apr 12, 2016: EKF Diagnostics Holdings: Final results

9.2.9 Apr 11, 2016: SteadyMed Announces Initiation Of Inter Partes Review Proceedings By U.S. Patent And Trademark Office Against A United Therapeutics Patent

9.3 Legal And Regulatory

9.3.1 Dec 07, 2016: Abbott Seeks To Terminate Alere Acquisition

9.3.2 Jul 04, 2016: Infringement procedure against Roche - EMA update

9.3.3 Mar 16, 2016: Decision Diagnostics and Subsidiaries Elaborate on the Patent Infringement Lawsuit Against Johnson & Johnson and Two of Its Divisions

9.4 Other Significant Developments

9.4.1 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction

9.4.2 Oct 13, 2016: Vigmed Signs Distribution Agreement For The Important Markets In The United Kingdom And Ireland

9.4.3 Mar 30, 2016: Mologic Selects for SBRI Healthcare Award

9.5 Strategy And Business Planning

9.5.1 Nov 14, 2016: Diabetes Management Leader Dexcom Expands Presence in EMEA Markets with new Edinburgh HQ

9.5.2 Nov 01, 2016: GE Healthcare enhances single-use manufacturing capabilities with facility expansion and automation

9.5.3 Jan 25, 2016: AstraZeneca partners with peers and academia to establish translational research fund

10 Appendix

10.1 Research Methodology

10.1.1 Coverage

10.1.2 Secondary Research

10.1.3 Primary Research

10.1.4 Company Share Analysis

10.1.5 Distribution Share Analysis

10.1.6 Benchmarking

10.2 Consulting

10.3 Contact Us

10.4 Disclaimer

1.1 List of Tables

Table 1: Diabetes Care Devices Market, United Kingdom, Revenue ($m), USD Constant, 2008-2022

Table 2: Diabetes Care Devices Market, United Kingdom, Category Contribution by Revenue ($m), 2015

Table 3: Diabetes Care Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2008-2015

Table 4: Diabetes Care Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2015-2022

Table 5: Diabetes Care Devices Market, United Kingdom, Volume (Units), 2008-2022

Table 6: Diabetes Care Devices Market, United Kingdom, Volume (Units), Historic, 2008-2015

Table 7: Diabetes Care Devices Market, United Kingdom, Volume (Units), Forecast, 2015-2022

Table 8: Diabetes Care Devices Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2015

Table 9: Glucose Monitoring Market, United Kingdom, Segment Contribution (%), 2015

Table 10: Glucose Monitoring Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2008-2015

Table 11: Glucose Monitoring Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2015-2022

Table 12: Blood Glucose Meters Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2008-2015

Table 13: Blood Glucose Meters Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2015-2022

Table 14: Glucose Monitoring Market, United Kingdom, Volume (Units), Historic, 2008-2015

Table 15: Glucose Monitoring Market, United Kingdom, Volume (Units), Forecast, 2015-2022

Table 16: Blood Glucose Meters Market, United Kingdom, Volume (Units), Historic, 2008-2015

Table 17: Blood Glucose Meters Market, United Kingdom, Volume (Units), Forecast, 2015-2022

Table 18: Glucose Monitoring Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2014-2015

Table 19: Glucose Monitoring Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2015

Table 20: Insulin Delivery Market, United Kingdom, Segment Contribution (%), 2015

Table 21: Insulin Delivery Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2008-2015

Table 22: Insulin Delivery Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2015-2022

Table 23: Insulin Pens Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2008-2015

Table 24: Insulin Pumps Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2008-2015

Table 25: Insulin Pens Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2015-2022

Table 26: Insulin Pumps Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2015-2022

Table 27: Insulin Delivery Market, United Kingdom, Volume (Units), Historic, 2008-2015

Table 28: Insulin Delivery Market, United Kingdom, Volume (Units), Forecast, 2015-2022

Table 29: Insulin Pens Market, United Kingdom, Volume (Units), Historic, 2008-2015

Table 30: Insulin Pumps Market, United Kingdom, Volume (Units), Historic, 2008-2015

Table 31: Insulin Pens Market, United Kingdom, Volume (Units), Forecast, 2015-2022

Table 32: Insulin Pumps Market, United Kingdom, Volume (Units), Forecast, 2015-2022

Table 33: Insulin Delivery Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2014-2015

Table 34: Insulin Delivery Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2015

Table 35: Diabetes Care Devices Market Pipeline Products

Table 36: Midatech Pharma Raises USD14.9 Million in Private Placement of Shares

Table 37: EKF Diagnostics Raises USD7 Million in Private Placement of Shares

Table 38: HCi Viocare to Raise up to USD34 Million in Public Offering of Shares

Table 39: JDRF Enters into Co-Development Agreement with Arecor

Table 40: Tandem Diabetes Care Enters into Licensing Agreement with TypeZero Technologies

Table 41: Senseonics Amends its Distribution Agreement with F. Hoffmann-La Roche

Table 42: Medtronic and Qualcomm Life Enter into Co-Development Agreement

Table 43: Metabolon Enters into Licensing Agreement with Synlab

Table 44: Cellnovo Enters into Agreement with Roche Diagnostics

1.2 List of Figures

Figure 1: Diabetes Care Devices Market, United Kingdom, Revenue ($m), USD Constant, 2008-2022

Figure 2: Diabetes Care Devices Market, United Kingdom, Revenue Mix ($m), 2015

Figure 3: Diabetes Care Devices Market, United Kingdom, Category Contribution (%), 2015

Figure 4: Diabetes Care Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2008-2015

Figure 5: Diabetes Care Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2015-2022

Figure 6: Diabetes Care Devices Market, United Kingdom, Volume (Units), 2008-2022

Figure 7: Diabetes Care Devices Market, United Kingdom, Volume (Units), Historic, 2008-2015

Figure 8: Diabetes Care Devices Market, United Kingdom, Volume (Units), Forecast, 2015-2022

Figure 9: Diabetes Care Devices Market, United Kingdom, Company Share (%) 2015

Figure 10: Glucose Monitoring Market, United Kingdom, Revenue Mix ($m), 2015

Figure 11: Glucose Monitoring Market, United Kingdom, Segment Contribution (%), 2015

Figure 12: Glucose Monitoring Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2008-2015

Figure 13: Glucose Monitoring Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2015-2022

Figure 14: Blood Glucose Meters Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2008-2015

Figure 15: Blood Glucose Meters Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2015-2022

Figure 16: Glucose Monitoring Market, United Kingdom, Volume (Units), Historic, 2008-2015

Figure 17: Glucose Monitoring Market, United Kingdom, Volume (Units), Forecast, 2015-2022

Figure 18: Blood Glucose Meters Market, United Kingdom, Volume (Units), Historic, 2008-2015

Figure 19: Blood Glucose Meters Market, United Kingdom, Volume (Units), Forecast, 2015-2022

Figure 20: Glucose Monitoring Market, United Kingdom, Company Share (%) 2015

Figure 21: Insulin Delivery Market, United Kingdom, Revenue Mix ($m), 2015

Figure 22: Insulin Delivery Market, United Kingdom, Segment Contribution (%), 2015

Figure 23: Insulin Delivery Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2008-2015

Figure 24: Insulin Delivery Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2015-2022

Figure 25: Insulin Pens Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2008-2015

Figure 26: Insulin Pumps Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2008-2015

Figure 27: Insulin Pens Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2015-2022

Figure 28: Insulin Pumps Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2015-2022

Figure 29: Insulin Delivery Market, United Kingdom, Volume (Units), Historic, 2008-2015

Figure 30: Insulin Delivery Market, United Kingdom, Volume (Units), Forecast, 2015-2022

Figure 31: Insulin Pens Market, United Kingdom, Volume (Units), Historic, 2008-2015

Figure 32: Insulin Pumps Market, United Kingdom, Volume (Units), Historic, 2008-2015

Figure 33: Insulin Pens Market, United Kingdom, Volume (Units), Forecast, 2015-2022

Figure 34: Insulin Pumps Market, United Kingdom, Volume (Units), Forecast, 2015-2022

Figure 35: Insulin Delivery Market, United Kingdom, Company Share (%) 2015
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
- F. Hoffmann-La Roche Ltd
- Sanofi
- LifeScan Inc
- Bayer HealthCare AG
- Becton Dickinson and Co
- Abbott Laboratories
- Eli Lilly and Company
- Novo Nordisk A/S
- B. Braun Melsunge
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll